Filter
6846
Filtered Results: 6846
Text search:
healthcare
programme
Featured
Recommendations
599
New Publications
1880
Language
Document type
No document type
3944
Studies & Reports
1124
Guidelines
811
Manuals
361
Strategic & Response Plan
265
Fact sheets
111
Training Material
102
Situation Updates
75
Resource Platforms
16
Brochures
14
Infographics
13
Online Courses
10
Countries / Regions
India
341
Global
264
Kenya
211
South Africa
185
Sierra Leone
157
Nigeria
138
Nepal
136
Western and Central Europe
130
Ethiopia
127
Uganda
126
Myanmar / Burma
120
Zambia
116
Liberia
109
Tanzania
106
Africa
103
Malawi
99
Bangladesh
95
Ghana
94
Syria
89
Ukraine
87
Rwanda
67
Congo, Democratic Republic of
66
Namibia
63
Latin America and the Carribbean
62
Eastern Europe
54
Zimbabwe
53
Lesotho
51
South–East Asia Region
51
Asia
48
South Sudan
48
Senegal
47
Guinea
41
Cambodia
41
Burkina Faso
37
Mozambique
37
Botswana
35
Philippines
34
East and Southern Africa
33
West and Central Africa
32
Indonesia
30
Middle East and North Africa
29
Russia
29
Yemen
28
Cameroon
25
Haiti
25
Venezuela
23
Eswatini/ Swaziland
22
Pakistan
22
Germany
21
Eastern Europe and Central Asia
21
Brazil
20
Western Pacific Region
19
Benin
18
Afghanistan
18
Lebanon
18
Jordan
17
Sudan
17
Mali
15
Colombia
14
Vietnam
13
Central African Republic
13
Somalia
13
Tajikistan
11
Sri Lanka
11
Iraq
11
Albania
10
Moldova
10
Georgia
10
Thailand
9
China
9
Laos
9
Côte d’Ivoire / Ivory Coast
9
Turkey
8
Kyrgyzstan
8
Peru
8
North Macedonia
7
Togo
6
Niger
6
Armenia
6
Paraguay
6
Jamaica
6
Southern Africa
6
Angola
6
Libya
6
Madagascar
6
Kazakhstan
5
Iran
5
Portugal
5
Chad
5
Mexico
4
Serbia
4
Gambia
4
Burundi
4
Hungary
4
United Kingdom
4
Argentina
4
Palestine
4
Poland
4
Bhutan
4
El Salvador
3
Italy
3
Guinea-Bissau
3
Turkmenistan
3
Japan
3
Mauritius
3
Spain
3
Bolivia
3
Papua New Guinea
3
Egypt
3
Romania
3
Greece
3
Ecuador
3
Timor Leste/ East Timor
2
Chile
2
Singapore
2
Estonia
2
Uzbekistan
2
Morocco
2
Qatar
2
Bulgaria
2
USA
2
Ireland
2
Saudi Arabia
2
Tunisia
2
Azerbaijan
2
Belarus
2
Bosnia and Herzegovina
2
Slovakia
2
Guatemala
2
North Korea
1
Canada
1
Fiji
1
Congo-Brazzaville
1
Mauritania
1
Croatia
1
Lithuania
1
North America
1
Gabon
1
Uruguay
1
Denmark
1
Belgium
1
France
1
Maldives
1
Norway
1
Algeria
1
Israel
1
Latvia
1
Nicaragua
1
Djibouti
1
Honduras
1
Authors & Publishers
Publication Years
Category
Countries
2667
Clinical Guidelines
502
Public Health
398
Women & Child Health
393
Key Resources
287
Capacity Building
122
Pharmacy & Technologies
72
Toolboxes
HIV
652
COVID-19
507
Mental Health
460
TB
394
Disability
300
Caregiver
238
Conflict
215
AMR
204
Planetary Health
190
Rapid Response
185
Ebola
180
NTDs
136
NCDs
133
Global Health Education
129
Refugee
122
Pharmacy
113
Natural Hazards
67
Health Financing Toolbox
59
Polio
30
Zika
29
Cholera
28
Specific Hazards
20
Social Ethics
20
Typhoon
3
South Sudan
1
Health Financing
1
APRIL 2021- JULY 2022
Trachoma is an eye infection that for thousands of years caused many people to go blind across all continents. As the result of development and targeted interventions, trachoma is now limited to an estimated 57 countries, often affecting the poorest
populations of the world. Today, more than 2 mill...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease is
found mainly in endemic areas of 21 Latin American countries. Chagas disease was once entirely
...
Yaws, a neglected tropical disease (NTD) of the skin caused by the bacterium Treponema pallidum subspecies pertenue, is targeted in the latest WHO NTD Roadmap for eradication by 2030. In January, 2022, WHO published a manual that outlines the key activities that Ministries of Health in endemic count...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) project has conducted a multi-year, multi-country study that provides stark insights on the under-reported depth of the antimicrobial resistance (AMR) crisis across Africa and lays out urgent policy recommendations to addr...
In 2015 around 15 million people living with HIV were receiving antiretroviral treatment (ART) in sub–Saharan Africa. Sustained provision of ART, though both prudent and necessary, creates substantial long–term fiscal obligations for countries affected by HIV/ AIDS. As donor assistance for healt...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
While epidemiological data for type 1 diabetes (T1D) in low/middle-income countries, and particularly low-income countries (LICs) including Liberia is lacking, prevalence in LICs is thought to be increasing. T1D care in LICs is often impacted by challenges in diagnosis and management. These challeng...
This guideline covers care and management for adults (aged 18 and over) with type 2 diabetes. It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.
The goal of asthma treatment is to obtain clinical control and reduce future risks to the patient. To reach this goal in children with asthma, ongoing monitoring is essential. While all components of asthma, such as symptoms, lung function, bronchial hyperresponsiveness and inflammation, may exist i...
The 2023 update of the Global Strategy for Asthma Management and Prevention incorporates new scientific information about asthma based on a review of recent scientific literature by an international panel of experts on the GINA Science Committee. This comprehensive and practical resource about one o...
Asthma is the most common non-communicable disease in children and remains one of the most common throughout the life course. The great majority of the burden of this disease is seen in low-income and middle-income countries (LMICs), which have disproportionately high asthma-related mortality relati...
